Alpha-2 adrenergic receptor development in rat CNS: An autoradiographic study

被引:88
作者
Happe, HK
Coulter, CL
Gerety, ME
Sanders, JD
O'Rourke, M
Bylund, DB
Murrin, LC [1 ]
机构
[1] Univ Nebraska, Ctr Med, Dept Pharmacol, Omaha, NE 68198 USA
[2] Creighton Univ, Coll Med, Dept Psychiat, Omaha, NE 68178 USA
[3] Creighton Univ, Coll Med, Dept Neurol, Omaha, NE 68178 USA
[4] Coll St Mary, Dept Biol, Omaha, NE 68124 USA
关键词
norepinephrine receptors; ontogeny; localization; norepinephrine; neuroanatomy;
D O I
10.1016/j.neuroscience.2003.09.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
During development norepinephrine plays a role in determining the morphologic organization of the CNS and the density and future responsiveness of adrenergic receptors. alpha-2 Adrenergic receptors, one of three adrenergic receptor types, regulate important adult CNS functions and may have a distinct role during development. We examined alpha-2 receptor distribution and density in the rat brain at postnatal days 1, 5, 10, 15, 21, 28 and in adults using the antagonist [H-3]RX821002 for autoradiography. Binding kinetics and pharmacology for alpha-2 adrenergic receptors were the same in adults and neonates. There was an overall increase in alpha-2 receptor levels during postnatal development with great variability in pattern and timing of receptor density changes among brain regions. Three major patterns were apparent. First, in many regions receptor density increased during postnatal development, generally reaching adult levels around postnatal day 15. Within this group there was variability in timing between regions and there were several regions with receptor densities higher than adult levels during the postnatal period. Second, there were regions with very high levels of receptors at birth and little or no change in density during the postnatal period. Third, some regions demonstrated decreasing or transient expression of alpha-2 adrenergic receptors in the course of postnatal development, including white matter regions, cerebellum and many brainstem nuclei, suggesting specific roles for alpha-2 receptors during development. This study investigates the development of alpha-2 adrenergic receptors in the rat CNS. It demonstrates there is region-specific regulation of alpha-2 receptor development and identifies brain regions where these receptors may play a specific and critical role in the regulation normal development. (C) 2003 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:167 / 178
页数:12
相关论文
共 50 条
[21]   NEUROTRANSMITTERS AS GROWTH REGULATORY SIGNALS - ROLE OF RECEPTORS AND 2ND MESSENGERS [J].
LAUDER, JM .
TRENDS IN NEUROSCIENCES, 1993, 16 (06) :233-240
[22]   Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain:: a selective ligand for imidazoline I2 receptors [J].
Lione, LA ;
Nutt, DJ ;
Hudson, AL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 353 (01) :123-135
[23]   NEUROTRANSMITTER REGULATION OF NEURONAL OUTGROWTH, PLASTICITY AND SURVIVAL [J].
LIPTON, SA ;
KATER, SB .
TRENDS IN NEUROSCIENCES, 1989, 12 (07) :265-270
[24]   NEUROTRANSMITTERS AS DEVELOPMENTAL SIGNALS [J].
MEIER, E ;
HERTZ, L ;
SCHOUSBOE, A .
NEUROCHEMISTRY INTERNATIONAL, 1991, 19 (1-2) :1-15
[25]  
Molderings GJ, 1998, J PHARMACOL EXP THER, V285, P170
[26]   CENTRAL CATECHOLAMINE NEURON SYSTEMS - ANATOMY AND PHYSIOLOGY OF THE NOREPINEPHRINE AND EPINEPHRINE SYSTEMS [J].
MOORE, RY ;
BLOOM, FE .
ANNUAL REVIEW OF NEUROSCIENCE, 1979, 2 :113-168
[27]   ONTOGENY OF ALPHA-1 AND ALPHA-2-ADRENOCEPTORS IN RAT-BRAIN [J].
MORRIS, MJ ;
DAUSSE, JP ;
DEVYNCK, MA ;
MEYER, P .
BRAIN RESEARCH, 1980, 190 (01) :268-271
[28]   Inverse agonism at α2-adrenoceptors in native tissue [J].
Murrin, LC ;
Gerety, ME ;
Happe, HK ;
Bylund, DB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 398 (02) :185-191
[29]   DEVELOPMENTAL-CHANGES OF CEREBRAL CORTICAL [H-3]LABELED CLONIDINE BINDING IN RATS - INFLUENCES OF GUANINE-NUCLEOTIDE AND CATIONS [J].
NOMURA, Y ;
KAWAI, M ;
MITA, K ;
SEGAWA, T .
JOURNAL OF NEUROCHEMISTRY, 1984, 42 (05) :1240-1245
[30]  
OROURKE MF, 1994, J PHARMACOL EXP THER, V268, P1362